Keywords: zambon, sheffield, begin, trials, ipratropium, msi, group

Zambon and Sheffield begin trials of ipratropium in MSI

Article | 05 January 2000

Zambon Group and Sheffield Pharmaceuticals have begun clinicaldevelopment of the bronchodilator ipratropium bromide administered using the latter's metered solution inhaler. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Sheffield

Go to company listing